Clinical Trial Update: Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects [Phase 4]

View source ↗

Summary

Phase 4 trial of melatonin vs placebo in Lennox-Gastaut syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Institution de Lavigny | Conditions: Lennox-Gastaut Syndrome | Phase 4 | Status: WITHDRAWN